- Oxford BioDynamics to ‘significantly’ expand UK facilities
Oxford BioDynamics, the biotechnology company, has signed a lease agreement for new laboratory and office space at Oxford Business Park which it intended to significantly expand its UK facilities as the Group continues the execution of its expanded strategic focus.
Eurasia Mining Plc
Oncimmune Holdings Plc
Royal Dutch Shell Plc
Shield Therapeutics Plc
Cambridge Cognition Holdings Plc
- Versarien receives £1.93m investment from South Korean firm Graphene Lab
Versarien, the advanced materials engineering group said it has entered into a wide-ranging series of agreements with Graphene Lab Co intended to advance both comapnie’s activities in South Korea. Meanwhile, Graphene Lab, which is a South Korean-based firm, has made a strategic investment of £1.93 million into Versarien.
- Open Orphan launches Disease in Motion® platform
Open Orphan, the specialist pharmaceutical services research organisation announced that its subsidiary, hVIVO, has officially launched its data-focused ‘Disease in Motion®’ platform which spans several conditions. hVIVO said it plans to expand this going forward.
- Alba Mineral Resources identifies three principal targets at Limerick Base Metals Project
Alba Mineral Resources, the mineral exploration and development firm, has identified three principal target areas at its Limerick Base Metals Project in Ireland following a structural review. It said the targets exhibited characteristics “which are favourable for zinc-lead mineralisation and provide renewed focus and impetus” to its exploration activities.